(Q38227109)

31 August 2017

title

The investigation of acute optic neuritis: a review and proposed protocol (English)

1 reference

31 August 2017

1 reference

1 reference

Clare L Fraser

5

0 references

Friedemann Paul

object named as

Friedemann Paul

9

0 references

Axel Petzold

object named as

Axel Petzold

1

0 references

Brian G Weinshenker

13

object named as

Brian Weinshenker

1 reference

31 August 2017

Mike P Wattjes

2

1 reference

31 August 2017

Fiona Costello

3

1 reference

31 August 2017

Jose Flores-Rivera

4

1 reference

31 August 2017

Kazuo Fujihara

6

1 reference

31 August 2017

Jacqueline Leavitt

7

1 reference

31 August 2017

Romain Marignier

8

1 reference

31 August 2017

Sven Schippling

10

1 reference

31 August 2017

Christian Sindic

11

1 reference

31 August 2017

Pablo Villoslada

12

1 reference

31 August 2017

Gordon T Plant

14

1 reference

31 August 2017

language of work or name

English

0 references

publication date

8 July 2014

1 reference

31 August 2017

published in

Nature Reviews Neurology

1 reference

31 August 2017

volume

10

1 reference

31 August 2017

issue

8

1 reference

31 August 2017

page(s)

447-458

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2014.108

31 August 2017

exact match

0 references

cites work

Management of acute optic neuritis

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

The time course and phenotype of Uhthoff phenomenon following optic neuritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Uhthoff's phenomena in MS--clinical features and pathophysiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Clinical and theoretical aspects of head movement dependent oscillopsia (HMDO)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Role of eye movement examination and subjective visual vertical in clinical evaluation of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Revised diagnostic criteria for neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

The neuronal organization of the retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

David Hubel and Torsten Wiesel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Top-down influences on visual processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

The origin of pain in optic neuritis. Determinants of pain in 101 eyes with optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

The Historical Origin of the Pulfrich Effect: A Serendipitous Astronomic Observation at the Border of the Milky Way

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

The Pulfrich phenomenon; clumsiness and collisions which can be ameliorated

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Assessing the severity of color vision loss with implications for aviation and other occupational environments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Joint-encoding of motion and depth by visual cortical neurons: neural basis of the Pulfrich effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Relationship of optic nerve and brain conventional and non-conventional MRI measures and retinal nerve fiber layer thickness, as assessed by OCT and GDx: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Reproducibility of retinal thickness measurements in healthy subjects using spectralis optical coherence tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Macular spectral domain optical coherence tomography findings in Tanzanian endemic optic neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Microcystic macular edema: retrograde maculopathy caused by optic neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

A dam for retrograde axonal degeneration in multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Metabolic changes in the visual cortex are linked to retinal nerve fiber layer thinning in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Quantifying axonal loss after optic neuritis with optical coherence tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Patterns of retinal damage facilitate differential diagnosis between Susac syndrome and MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Differentiating retinal from optic nerve syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

The retinal nerve fiber layer of patients with neuromyelitis optica and chronic relapsing optic neuritis is more severely damaged than patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Evaluation of inner retinal layers in patients with multiple sclerosis or neuromyelitis optica using optical coherence tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Optic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Early high-dose intravenous methylprednisolone is effective in preserving retinal nerve fiber layer thickness in patients with neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Microcystic macular oedema in multiple sclerosis is associated with disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Microcystic macular oedema confirmed, but not specific for multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Microcystic inner nuclear layer abnormalities and neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

In vivo identification of morphologic retinal abnormalities in neuromyelitis optica

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

The OSCAR-IB consensus criteria for retinal OCT quality assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Clinical practice. Vitamin B12 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Low vitamin B12 levels and gastric parietal cell antibodies in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Use of corticosteroid sparing systemic immunosuppression for treatment of corticosteroid dependent optic neuritis not associated with demyelinating disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Optic neuritis as a possible phenotype of anti-GQ1b/GT1a antibody syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Seronegative NMO: a sensitive AQP4 antibody test clarifies clinical features and next challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Aquaporin-4 antibodies (NMO-IgG) as a serological marker of neuromyelitis optica: a critical review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

NMO-IgG predicts the outcome of recurrent optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

The utility of cerebrospinal fluid analysis in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Intrathecal oligoclonal IgG synthesis in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: Results from 211 lumbar punctures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Astrocytic damage is far more severe than demyelination in NMO: a clinical CSF biomarker study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Cerebrospinal fluid interleukin-6 and glial fibrillary acidic protein levels are increased during initial neuromyelitis optica attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Can we prevent or treat multiple sclerosis by individualised vitamin D supply?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

The influence of nutritional factors on the prognosis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Axonal degeneration and inflammation in acute optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

The diagnostic and prognostic value of neurofilament heavy chain levels in immune-mediated optic neuropathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Noninvasive assessments of optic nerve neurodegeneration in transgenic mice with isolated optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Imaging outcomes for neuroprotection and repair in multiple sclerosis trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Magnetic resonance imaging of the optic nerve in optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Magnetic resonance imaging of optic neuritis in patients with neuromyelitis optica versus multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

High field MRI in the diagnosis of multiple sclerosis: high field-high yield?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Demonstration of systematic variation in human intraorbital optic nerve size by quantitative magnetic resonance imaging and histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Optic nerve diffusion tensor imaging in optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Nonconventional optic nerve imaging in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

MRI acquisition and analysis protocol for in vivo intraorbital optic nerve segmentation at 3T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Electrodiagnostic assessment in optic nerve disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Pattern electroretinography (PERG) and an integrated approach to visual pathway diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

ISCEV standard for clinical visual evoked potentials (2009 update).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Visual evoked cortical potentials and pattern electroretinograms in Parkinson's disease and control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Multifocal visual evoked potential latency analysis: predicting progression to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

The incidence of abnormal pattern electroretinography in optic nerve demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Optic nerve head component responses of the multifocal electroretinogram in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Embolic and nonembolic transient monocular visual field loss: a clinicopathologic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Comparison of the new perimetric GATE strategy with conventional full-threshold and SITA standard strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Prevalence of organic neuro-ophthalmologic disease in patients with functional visual loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Optic Neuropathy from Cobalt Toxicity in a Patient who Ingested Cattle Magnets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Scleritis: Immunopathogenesis and molecular basis for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Recurrent Optic Perineuritis after Intranasal Cocaine Abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Clinical and laboratory features of neuromyelitis optica with oligoclonal IgG bands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Long-term fluctuation of relative afferent pupillary defect in subjects with normal visual function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Taking the temperature of MS with INO

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Re: Abegg et al.: Microcystic macular edema: retrograde maculopathy caused by optic neuropathy (Ophthalmology 2014;121:142-9).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Longitudinal follow-up of vision in a neuromyelitis optica cohort

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Structural brain abnormalities are related to retinal nerve fiber layer thinning and disease duration in neuromyelitis optica spectrum disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

The clinical spectrum of microcystic macular edema

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Post-fever retinitis: a single center experience from south India

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Glial but not axonal protein biomarkers as a new supportive diagnostic criteria for Devic neuromyelitis optica? Preliminary results on 188 patients with different neurological diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Visual recovery following acute optic neuritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Distinguishing optic neuritis in neuromyelitis optica spectrum disease from multiple sclerosis: a novel magnetic resonance imaging scoring system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Does high field MRI allow an earlier diagnosis of multiple sclerosis?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Optic nerve magnetization transfer imaging and measures of axonal loss and demyelination in optic neuritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Electroretinogram findings in unilateral optic neuritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Electropysiologic Evaluation of the Visual Pathway in Patients With Multiple Sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Visual field defects in optic neuritis and anterior ischemic optic neuropathy: distinctive features

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Optic perineuritis: clinical and radiographic features

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Separating the retinal electrophysiologic effects of vigabatrin: treatment versus field loss

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Visual field loss in senile dementia of the Alzheimer's type

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Optic nerve axon count and axon diameter in patients with ocular hypertension and normal visual fields

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2014.108

Effect of instructions on conventional automated perimetry.

31 March 2020

1 reference

12 December 2020

Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons

1 reference

12 December 2020

Visual evoked potential abnormalities in migraine patients.

1 reference

12 December 2020

Dissecting structure-function interactions in acute optic neuritis to investigate neuroplasticity.

1 reference

12 December 2020

Visual-vestibular interaction in multiple sclerosis

1 reference

12 December 2020

Human optic nerve fiber count and optic disc size

1 reference

12 December 2020

Automated perimetry. American Academy of Ophthalmology

1 reference

12 December 2020

10.1038/NRNEUROL.2014.108

Identifiers

DOI

1 reference

Dimensions Publication ID

31 August 2017

1041094746

0 references

1 reference